NewRegen, Inc.

Equities

NREG

US85179A1034

Healthcare Facilities & Services

Market Closed - OTC Markets Other stock markets 19:39:05 07/06/2024 BST			5-day change	1st Jan Change
0.008 ^USD	-15.79%		-11.11%	-52.94%

01-12	PickleJar Entertainment Group Announces Launch of its Digital Marketing Services Solution, FanVivo	CI
2023	NewRegen, Inc. Announces Resignation of Everett Dickson as Director	CI

Avra Inc. Reports Earnings Results for the Full Year Ended January 31, 2019

June 21, 2019 at 09:51 pm

Avra Inc. announced earnings results for the full year ended January 31, 2019. For the full year, the company announced operating loss was USD 97,780 compared to USD 90,906 a year ago. Net loss was USD 109,423 compared to USD 83,823 a year ago.

Latest news about NewRegen, Inc.

PickleJar Entertainment Group Announces Launch of its Digital Marketing Services Solution, FanVivo	01-12	CI
NewRegen, Inc. Announces Resignation of Everett Dickson as Director	11-27	CI
PickleJar Holdings, Inc. acquired NewRegen, Inc. in a reverse merger transaction.	11-26	CI
NewRegen, Inc. Widens Expansion Plans of Geographic Markets With Strategic Partner Marketing Program	27/06/23	CI
Springs Rejuvenation, LLC cancelled the acquisition of Avra Inc. in a reverse merger transaction.	20/09/22	CI
AVRA, Inc. has Changed its Name to Springs Rejuvenation Inc	09/03/22	CI
Avra, Inc Expands Atlanta Operations	02/03/22	CI
Avra, Inc. Signs Lease For New Fort Lauderdale FL Clinic Location	24/01/22	CI
Avra, Inc. Announces 2022 Expansion, Plans Rapid Expansion of Clinics in Us	18/01/22	CI
Springs Rejuvenation, LLC has signed an letter of intent to acquire Avra Inc. in a reverse merger transaction.	28/10/21	CI
Avra Inc. Reports Earnings Results for the Full Year Ended January 31, 2019	21/06/19	CI
Avra Inc. Reports Earnings Results for the Third Quarter Ended October 31, 2018	04/02/19	CI
Avra, Inc. Announces the Introduction of AvraSecure	20/04/15	CI
Avra Appoints Vasiliy Smetanin as Vice President of ATM and Kiosk Operations	20/01/15	CI
Avra, Inc. Appoints Mr. Mark Petropolous to the Position of Vice President of Sales for North America	08/01/15	CI
Avra Inc. Finalizes Technology Partnership with T2M International Inc	31/12/14	CI
Avra Inc. Enters Letter of Intent with Mango Pay SRL to Launch Digital Currency in Carribbean	05/12/14	CI
Avra Inc. announced that it has received $0.15 million in funding.	05/12/14	CI
Chief Executive Officer and Director of the Avra, Stephen Shepherd, acquired 56.27% stake in Avra Inc. from David Bailey for $0.06 million.	30/11/14	CI
Avra Inc. will Change its Ticker to AVRN from AVRND	22/07/14	CI
Avra Inc. will Change its Ticker to AVRND from AVRN	23/06/14	CI
Avra Inc. Announces Executive Changes	05/06/14	CI
Avra Inc. will Change its Ticker to AVRNE from AVRN	22/03/13	CI

Chart NewRegen, Inc.

Duration

Period

More charts

Company Profile

Newregen, Inc. provides anti-aging and regenerative medical treatments. It operates two brick and mortar and one Affiliated clinic. These are located in Atlanta, GA, Ft Lauderdale, FL and Tupelo MS. Its treatments have shown outcomes in autoimmune, inflammatory, neurological, and orthopedic conditions, injuries and other chronic pains. It is also focused on expanding its operations in FL and GA by adding additional affiliate clinics. It offers various services, including hormone replacement therapy, allograft suspension (stem cell) therapy, longevity, immunity, testosterone replacement therapy, weight management and others. It also offers multiple forms of hormone therapy, peptide therapy, cellular therapy, and other wellness therapies that complement their core services. The hormone replacement therapy treats a range of naturally occurring symptoms, including weight gain, increased body fat/decreased muscle mass, low energy, hair loss and others. Its subsidiary is ReGenMD, Inc.

Sector

Healthcare Facilities & Services

More about the company

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
NEWREGEN, INC.	-52.94%	602K
HCA HEALTHCARE, INC.	+24.66%	88.22B
CVS HEALTH CORPORATION	-21.76%	76.5B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+1.76%	26.97B
FRESENIUS SE & CO. KGAA	+7.94%	18.61B
LABCORP HOLDINGS INC.	-13.50%	16.72B
QUEST DIAGNOSTICS INCORPORATED	+3.23%	15.85B
NATERA, INC.	+77.51%	13.41B
TENET HEALTHCARE CORPORATION	+76.96%	13.16B
UNIVERSAL HEALTH SERVICES, INC.	+23.02%	12.67B

Other Healthcare Facilities & Services